Le Lézard
Classified in: Health
Subjects: SVY, AVO

Dialysis Patient Citizens Responds to Disappointing Final CMS Rule That Will Harm Patient Healthcare


WASHINGTON, Oct. 30, 2023 /PRNewswire/ -- Dialysis Patient Citizens (DPC), the nation's largest patient-led, non-profit advocacy group for dialysis patients, released the following statement in response to the final rule issued by the Centers for Medicare and Medicaid Services (CMS) which only increases Medicare reimbursements for dialysis treatment centers by 1.6% and fails to properly fund access to new therapies.

"The End Stage Renal Disease (ESRD) final rule released on Friday paints a chilling picture of an agency that is completely indifferent to the suffering of dialysis patients," said DPC President Andrew Conkling. "The regulation acknowledges the heartbreaking stories from patients like me who have experienced disruptions to their care due to workforce shortages but takes no meaningful steps toward helping healthcare providers compete in the already tight labor market with higher pay. Meanwhile, in direct contradiction to the Biden Administration's official pronouncements about the economy, CMS continues to insist that a recession, which may or may not happen, will soon 'update' its heretofore inaccurate economic forecasts.

"The rule also refuses to acknowledge the injustice of dialysis patients who experience pruritis (itching) being unable to obtain a new, effective treatment for this condition, due to the agency's inflexible dialysis payment methodology. The rule further solidifies an outrageous status quo, perpetuating unnecessary suffering and deterring researchers and venture capitalists from pursuing improvements to kidney care. CMS needs to do more than just acknowledge the plight of dialysis patients ? it should take concrete steps to increase access to life-saving treatments."

Contact: Hannah Bracamonte, [email protected]

SOURCE Dialysis Patient Citizens


These press releases may also interest you

at 03:00
Clarivate Plc , a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligencetm solution, featuring a new post-approval variations module. The module for post-approval variations...

at 03:00
Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and their patients at this year's 2024 European Society for Radiation Oncology (ESTRO) annual meeting,...

at 02:58
Today, 2 May 2024, is the last day of trading in unit rights in SciBase Holding AB (publ) ("SciBase" or the "Company") rights issue of units of up to approximately SEK 15 million (the "Rights Issue"). The Rights Issue was resolved by the Board of...

at 02:34
SciBase Holding AB ("SciBase") (STO: SCIB), a pioneer in skin cancer detection and prevention, and prediction in dermatology, further deepens their commitment to patients and dermatologists during US Skin Cancer Awareness Month by highlighting the...

at 02:14
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that Dra. Beatriz Guil of Universitario de Canarias in the Canary Islands and Dr. Carlos Milliani of Universitario de Fuenlabrada in...

at 02:00
YourBio Health, a Boston-based pioneer in remote, capillary whole blood collection technology, congratulates Myriad Genetics for having sold one million of its leading SneakPeek® Tests. Since 2021, YourBio Health is pleased to have contributed over...



News published on and distributed by: